eISSN: 1644-4124
ISSN: 1426-3912
Central European Journal of Immunology
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
1-2/2006
vol. 31
 
Share:
Share:
abstract:

Clinical immunology
Periodontal disease and cytokine inhibitors

Sylwia Małgorzata Słotwińska
,
Robert Słotwiński

(Centr Eur J Immunol 2006; 31 (1-2): 22-24)
Online publish date: 2006/10/12
View full text Get citation
 
The aim of the presented paper was to examine the occurrence in saliva of interleukin – 1 receptor antagonist (IL-1 ra) and soluble receptor type I of tumor necrosis factor (sTNF RI) in patients with periodontitis. The levels of interleukin-1 receptor antagonist and soluble TNF receptor type I (s TNF RI, p55) in saliva were determined with an immunoenzymatic ELISA method using a factory-ready quantitative enzymatic test manufactured by Quantikine, R&D System. The level of occurrence for interleukin-1 receptor antagonist (IL-1 ra) in saliva was statistically significantly higher (p<0.05) in persons with periodontitis as compared with the control group.
keywords:

periodontal disease, interleukin – 1 receptor antagonist (IL-1 ra), soluble receptor type I of tumor necrosis factor (sTNF RI)

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.